2017 American Transplant Congress
Gastrointestinal Perforation After Liver Transplantation in Pediatric Patients.
Introduction: The improved surgical techniques, antirejection treatment, and postoperative management have made liver transplantation (LT) the treatment of choice for pediatric patients with end-stage liver…2017 American Transplant Congress
Outcomes After Hysterectomy in Patients with End Stage Renal Disease.
INTRODUCTION:Hysterectomy is one of the most common gynecologic surgeries performed on women, including women with ESRD awaiting kidney transplantation. Despite this, studies of hysterectomy among…2017 American Transplant Congress
Spiritual and Religious Faith of Actual and Potential Non-Directed (Altruistic) Living Kidney Donors.
A. The recent rise in non-directed donors (NDDs) and their initiation of kidney chains offer innovative approaches to help address the overburdened kidney transplant waiting…2017 American Transplant Congress
Live Donor (LDTx) HIV(+) Kidney Transplantation Improves Allograft Survival vs. Deceased Donor (CRD) Transplantation.
Drexel University College of Medicine, Philadelphia
Hahnemann University Hospital has performed 113 kidney transplants in HIV(+) recipients. We sought to analyze the impact of HIV(+) LDTx on allograft survival.Methods: The HIV(+)…2017 American Transplant Congress
Assessment of the Risk Index for Living Donor Kidney Transplantation (LKDPI) in a European Cohort.
Nephrology, Charité Universitaetsmedizin, Berlin, Germany
Introduction: Recently, a risk index for living donor kidney transplantation (LKDPI) was proposed (Massie et al. AJT 2016) to compare living donor kidneys (LDK) to…2017 American Transplant Congress
Meta-Analysis of Clinical Significance of Complement Activating Anti-HLA DSA in Kidney Transplantation.
Donor-specific anti-HLA antibodies (DSA) are currently recognized as the major limitation to access transplantation and the first cause of late transplant failures. The effect of…2017 American Transplant Congress
ABO-Incompatibility Using Ritiuximab Does Not Increase Hepatocellular Carcinoma Recurrence After Liver Transplantation.
Background and aims: ABO-incompatible (ABO-I) living donor liver transplantation (LDLT) has a high success rate. However, a difference in hepatocellular carcinoma (HCC) recurrence rates has…2017 American Transplant Congress
Analysis of Outcomes in High Risk Kidney Transplants.
Kidney and Pancreas Transplantation, NewYork-Presbyterian Weill Cornell Medical Center, New York, NY
Background: The new kidney allocation system implemented in 12/2014 utilizes estimated post-transplant survival scores (EPTS) and kidney donor profile index (KDPI) to optimize recipient survival…2017 American Transplant Congress
Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate Risk Renal Transplants: A Single Center Experience.
1Infectious Diseases, Yale University, New Haven, CT; 2Pharmacy, YNHH, New Haven, CT
IntroductionCurrent guidelines on cytomegalovirus (CMV) prophylaxis following organ transplant recommend using valganciclovir (VGCV) 900 mg daily for high (CMV D+/R-) and intermediate (CMV R+) risk…2017 American Transplant Congress
Risk Analysis of Patients with Proven Coronary Artery Disease Undergoing Liver Transplant.
Houston Methodist Hospital, Houston, TX
ObjectivesCoronary artery disease is increasing common in liver transplant (LT) candidates due to the aging population. We sought to longitudinally evaluate of outcomes of LT…
- « Previous Page
- 1
- …
- 106
- 107
- 108
- 109
- 110
- …
- 155
- Next Page »